Ep. 50: mRNA vaccines in India ft. Soham Sankaran

Bretton Goods

Content provided by Pradyumna Prasad. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pradyumna Prasad or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

1M ago 1:01:43

MP3•Episode home

I spoke to Soham Sankaran who runs PopVax, an Indian mRNA vaccine company. Their goal is to build low-cost broadly-protective vaccines to protect against the entire sarbecovirus species. Read Soham's experience here (https://chronicles.popvax.com/p/three-meetings-and-six-million-funerals) as a complement to this episode. Also check out their jobs page (https://jobs.popvax.com/) for opportunities.

This episode includes

How he started PopVax and (went bankrupt in the process)
Why there hasn't been a successful Indian mRNA vaccine yet
Why developing countries can't afford drugs for rare diseases
What they're doing to fix it
Their biggest constraints

--- Send in a voice message: https://podcasters.spotify.com/pod/show/pradyumna-sp/message

53 episodes

#Science #Social Sciences #Pradyumna Shyama Prasad

Bretton Goods